March 13, 2017 / 11:48 AM / in 4 months

BRIEF-Minerva Neurosciences reports Q4 loss per share of $0.27

1 Min Read

March 13 (Reuters) - Minerva Neurosciences Inc

* Minerva Neurosciences reports fiscal 2016 fourth quarter and year end financial results and business updates

* Q4 loss per share $0.27

* Expects to initiate phase III testing of min-101 in schizophrenic patients with negative symptoms in second half of 2017

* Expects existing cash,cash equivalents will be sufficient to meet anticipated capital requirements for at least next 12 months Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below